An Indian works at Ranbaxy Laboratories Ltd's plant in Paonta Sahib, in the northern Indian state of Himachal Pradesh, in this undated handout photograph. The Indian generic drug maker on Wednesday offered to supply the USA with 20 million tablets a month of the anthrax antibiotic, reopening controversy about whether drug patents should hold in medical emergencies. —REUTERS